21:25:44 EDT Wed 30 Sep 2020
Enter Symbol
or Name

Login ID:

Cannabis Summary for Sept. 8, 2020

2020-09-08 19:43 ET - Market Summary

This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

Amidst another broad market decline, the S&P/TSX Cannabis Index lost 3.16 points to 121 Tuesday, while the Canadian Securities Exchange Composite Index slipped 2.51 points to 451.86. In Canada, Aurora Cannabis Inc. (ACB) dropped $1.20 to $9.92 on 4.1 million shares after appointing its new CEO (the long-awaited successor to Aurora founder Terry Booth) and outlining preliminary results for fiscal Q4, for the quarter ended June 30. The preliminary results include a quarterly impairment charge of approximately $1.7-billion.

It is a decidedly different market reaction to Aurora's fiscal third quarter results, when the stock nearly tripled. In the week after those results came out, Aurora went from $9.20 to a high of $26.79. As shareholders know well, those gains did not last. The stock has steadily come down since then, and today's $9.92 closing price is hardly above the $9.20 that Aurora was trading at when it released its Q3 results.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

© 2020 Canjex Publishing Ltd. All rights reserved.

Reader Comments - Comments are open to paying subscribers of Stockwatch and unmoderated, although libelous remarks, obscene language and impersonations may be deleted. Opinions expressed do not necessarily reflect the views of Stockwatch.
For information regarding Canadian libel law, please view the University of Ottawa's FAQ regarding Defamation and SLAPPs.